RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib
Clinical trial NCT00410124 · COMPLETED
Trial details
- NCT number
- NCT00410124
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-02-01
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.